Epidemiologic studies have reported relationships between maternal high folate and/or low B 12 status during pregnancy and greater adiposity and insulin resistance in children. The goal of this study was to determine the effects of maternal folic acid supplementation (10 mg/kg diet), with (50 mg/kg diet) and without B 12 , on adult female offspring adiposity and glucose homeostasis. Female C57BL/6J mice were fed 1 of 3 diets from weaning and throughout breeding, pregnancy, and lactation: control (2 mg/kg diet folic acid, 50 mg/kg diet B 12 ), supplemental folic acid with no B 12 (SFA2B 12 ), or supplemental folic acid with adequate B 12 (SFA+B 12 ). Female offspring were weaned onto the control diet or a Western diet (45% energy fat, 2 mg/kg diet folic acid, 50 mg/kg diet B 12 ) for 35 wk. After weaning, control diet-fed offspring with SFA2B 12 dams had fasting hyperglycemia, glucose intolerance, lower b cell mass, and greater islet hepatocyte nuclear factor 1 homeobox a and nuclear receptor subfamily 1 group H member 3 mRNA than did offspring from control dams. In Western diet-fed offspring, those with SFA2B 12 dams had lower fasting blood glucose and plasma insulin concentrations, and were smaller than control offspring. Our findings suggest that maternal folic acid supplementation with B 12 deficiency during pregnancy/lactation programs the metabolic health of adult female offspring but is dependent on offspring dietMaternal folic acid supplementation with vitamin B 12 deficiency during pregnancy and lactation affects the metabolic health of adult female offspring but is dependent on offspring diet. FASEB J. 32, 5039-5050 (2018). www.fasebj.org KEY WORDS: adiposity • developmental programming • folate • glucose homeostasis • maternal diet
The developmental origins of health and disease theory suggest that environment during development can contribute to the risk for chronic disease, such as obesity and type 2 diabetes mellitus, later in life (1) . The B vitamin folate is an important nutrient during development; it is required for DNA synthesis and the transfer of methyl groups in numerous metabolic reactions (2, 3) . Many countries, including Canada and the United States, have implemented mandatory fortification of grain products with folic acid, a synthetic form of folate, to reduce the incidence of neural tube defects (NTDs) at birth (4, 5) . As a result, folate deficiency (erythrocyte folate ,320 nM) has become rare (6) (7) (8) ; in fact, 63.5% of Canadians now exhibit high folate status (erythrocyte folate .1090 nM) (9) . The folic acid fortification policy has been adapted by many countries worldwide and has been very successful at reducing the incidence of NTDs (4, 5) and congenital heart defects (10) . However, concern has been raised regarding the high intakes of folic acid because of the combined use of supplements and the fortification policy (3) .
In this context, concern about an imbalance in maternal B-vitamin status during pregnancy and the metabolic health of the child has recently been raised and stems from findings of epidemiologic studies that report relationships ABBREVIATIONS: 5-MTHF, 5-methylenetetrahydrofolate; AdoHcy, S-adenosylhomocysteine; AdoMet, S-adenosylmethionine; Hnf1a, HNF1 hepatocyte nuclear factor 1 homeobox a; Igfbp2, insulin-like growth factor binding protein 2; Mafa, MAF bZIP transcription factor A; Mthfr, methylenetetrahydrofolate reductase; Mtr, 5-methyltetrahydrofolate-homocysteine methyltransferase; Nr1h3, nuclear receptor subfamily 1 group H member 3; NTD, neural tube defects; OCR, oxygen consumption rate; SFA2B 12 , supplemental folic acid with no vitamin B 12 ; SFA+B 12 , supplemental folic acid with adequate vitamin B 12 between maternal folate/B 12 status during pregnancy and adiposity and insulin resistance in children (11) (12) (13) . For example, the Pune Maternal Nutrition Study (11) reported that high maternal erythrocyte folate concentrations (.1144 nM) during pregnancy (28 wk) were predictive of greater adiposity and insulin resistance, as determined by the homeostatic model assessment and insulin resistance model, in children at age 6 yr, and children from mothers with high erythrocyte folate concentrations but low B 12 status (plasma B 12 ,114 pM) had the greatest insulin resistance. Similarly, a study in Nepal (12) reported that children born to mothers with low B 12 status (serum B 12 ,148 pM) during the first trimester of pregnancy had greater insulin resistance at 6-8 yr old compared with children from mothers with adequate B 12 status. Of relevance, recent population-based studies report that ;5% of Canadians, including women in early pregnancy, are estimated to be vitamin B 12 deficient based on serum B 12 ,148 pM (9, 14) .
Although epidemiologic studies have reported that folate and vitamin B 12 status during pregnancy affects offspring metabolic health, the molecular mechanisms contributing to such effects remain unclear. Folate and B 12 are metabolically linked; both vitamins are required for the methionine synthase catalyzed remethylation of homocysteine to methionine. Some studies conducted in rodent models have focused solely on investigating the effects of maternal supplementation with just folic acid or supplementation or deficiency of several B vitamins and other methyl donors on offspring body weight and glucose tolerance (15) (16) (17) (18) (19) (20) (21) (22) . Most of those studies were conducted only in male offspring, and little is known about the mechanisms underlying the effects of maternal B vitamin status on offspring adiposity and glucose homeostasis. Further studies are required to advance our understanding on the effect of maternal folic acid/B 12 imbalance during pregnancy on offspring metabolic health to inform policy guidelines for pregnant women. In the present study, we determined the effects of maternal folic acid supplementation, with and without B 12 , on adult female offspring adiposity and glucose homeostasis and explored mechanisms contributing to the phenotype we observed.
MATERIALS AND METHODS

Mice and diets
Female C57BL/6J mice were weaned on to 1 of 3 diets: control (2 mg/kg folic acid + 50 mg/kg B 12 ); supplemental folic acid with no B 12 (SFA2B 12 ; 10 mg/kg folic acid + 0 mg/kg B 12 ); or supplemental folic acid with adequate B 12 (SFA+B 12 , 10 mg/kg folic acid + 50 mg/kg B 12 ), and maintained on the diets throughout breeding, pregnancy, and lactation, as described in Aleliunas et al. (23) . Details on the nutrient composition of the diets are given in Table 1 and are the same as those used in the Aleliunas et al. study (23) . The female mice (dams) were bred with male C57BL/6J mice fed the control diet at 6 wk after weaning. Female offspring mice were weaned onto either the control diet or a Western diet (45% energy fat; Table 1 ) and were maintained on the diet for 35 wk. Mice were housed 3-5 animals/cage under standard 12-h light/dark cycles and given food and water ad libitum. The female offspring were categorized based on the diet of the dams: control offspring, SFA2B 12 offspring, and SFA+B 12 offspring. Body composition (fat and lean mass) was quantified in live, conscious animals using quantitative magnetic resonance (EchoMRI-100; Echo Medical Systems, Houston, TX, USA) in the mice at 3-5 d before the end of the feeding period; 3 scans/animal were averaged to determine fat mass and lean mass. At the end of the feeding period, mice were anesthetized with isoflurane, blood was collected via cardiac puncture, and death was confirmed by cervical dislocation. Serum was isolated from blood and stored at 280°C. Liver and adipose tissue were flash frozen in liquid nitrogen and stored at 280°C. Pancreata were placed in paraformaldehyde for later immunohistochemistry. All procedures were performed in accordance with the guidelines and approval of the University of British Columbia Animal Care Committee.
Glucose tolerance
Intraperitoneal glucose tolerance tests were performed 3-5 d before the end of the feeding period after 5-h of being unfed, as previously described (23, 24) . Blood was collected from the saphenous vein into EDTA tubes at baseline, and plasma was separated by centrifugation at 6000 g at 4°C for 10 min. Blood glucose was quantified at baseline and at 15, 30, 60, 90, and 120 min after injection. Fasting serum insulin was quantified at baseline with the Mouse Ultrasensitive Insulin ELISA (Alpco, Salem, NH, USA).
Pancreatic islet isolation
In a subset of mice, islets were isolated by collagenase digestion as previously described (25, 26) . Collagenase (3 ml, 1000 IU/ml; MilliporeSigma, Burlington, MA, USA) in HBSS (Thermo Fisher Scientific, Waltham, MA, USA) was injected into the common bile duct, and pancreata were dissected and incubated at 37°C for 15 min. Islets were isolated by passing the digested pancreata through 70-mm nylon filters. The islets were flash frozen and stored at 280°C until later RNA extraction.
a/b Cell masses
Paraformaldehyde-fixed, paraffin-embedded pancreata were serially sectioned and stained with guinea pig anti-mouse insulin and rabbit-anti-mouse glucagon (1:200, Dako brand; Agilent Technologies, Santa Clara, CA, USA) primary antibodies, followed by Alexa Fluor 594 goat anti-guinea pig IgG (Thermo Fisher Scientific) and Alexa Fluor 488 goat anti-rabbit IgG secondary antibodies (1:200; Thermo Fisher Scientific). Slides were visualized with a BX61 microscope (Olympus, Tokyo, Japan) and quantified by Image-Pro Plus software (Media Cybernetics, Rockville, MD, USA). a/b cell masses were calculated by averaging 8 sections/ pancreas: insulin or glucagon positive area/pancreas section area 3 100 3 pancreas weight.
Biochemical analyses
Serum IGF-1 and leptin concentrations were quantified with commercial ELISA kits (Alpco). Serum folate concentrations were quantified with a microbiological assay and the chloramphenicol-resistant strain of Lactobacillus casei [National Center for Biotechnology Information (NCIB), strain 10463; Cedarlane, Burlington, ON, Canada] (27) . Serum B 12 concentrations were quantified with a microbiological kit and Lactobacillus delbrueckii subsp. lactis-coated microtiter plates (ID-Vit Vitamin-B 12 ; Immundiagnostik, Bensheim, Germany). Liver S-adenosylmethionine (AdoMet) and S-adenosylhomocysteine (AdoHcy) concentrations were quantified by HPLC with UV detection using the methods of Fell et al. 
Gene expression
Real-time PCR and the cycle threshold DDC t method of relative quantification (30, 31) were used to quantify mRNA levels of target genes. Total RNA was extracted from liver with the RNeasy Mini Kit (Qiagen, Hilden, Germany) and from islets with the All Prep Kit (Qiagen). RNA (500 ng) was reverse transcribed with the high-capacity cDNA RT Kit (Thermo Fisher Scientific). TaqMan Gene Expression Master Mix (Thermo Fisher Scientific), and the following mouse-specific primers (Thermo Fisher Scientific) were used to quantify mRNA levels: cystathionineb-synthase (Cbs) (Mm_00460654), hepatocyte nuclear factor 1 homeobox a (Hnf1a) (Mm_00493434), Igf1 (Mm_004395601), insulin-like growth factor binding protein 2 (Igfbp2) (Mm_ 00492632m1), MAF bZip transcription factor A (Mafa) (Mm_ 00845206), Mat1a (Mm_00522563), Mthfr (Mm_0 12 55752), 5-metyltetrahydrofolate-homocysteine methyltranferase (Mtr) (Mm_01340053), nuclear receptor subfamily 1 group H member 3 (Nr1h3) (Mm_00443451), and 18S rRNA (Mm_04277571) as the endogenous control. The data were analyzed, and the relative expression was calculated with 7500 System Sequence Detection Software (Thermo Fisher Scientific). A sample from each mouse was run in duplicate; expression of each gene was repeated twice for all mice, and the means of the 2 experiments are presented.
Mitochondrial respiration in 3T3-L1 adipocytes
Mitochondrial respiration rates were determined in differentiated mouse 3T3-L1 adipocytes with the Seahorse XFe96 Extracellular Flux Analyzer (Agilent Technologies) and Mito Stress Test (Agilent Technologies). Seahorse XF96 Cell Culture Microplates (Agilent Technologies) were coated with poly-D-lysine and 3T3-L1 cells (CL-173; American Type Culture Collection, Manassas, VA, USA) were seeded at 5 3 10 3 cells/well. Cells were maintained for the duration of the experiment in complete Roswell Park Memorial Institute (RPMI)-1640 medium with no folic acid (Thermo Fisher Scientific) with 10% fetal bovine serum, and supplemented with the following concentrations of folic acid or 5-methyltetrahydrofolate (5-MTHF): 0.16 (circulating concentration in control mice), 0.8, or 1.6 mM. The RPMI medium contained 3.7 nM B 12 , which is more than the serum B 12 concentrations of the dams fed the SFA2B 12 diet (0.57 6 0.07 nM, means 6 SD) but much less than the serum B 12 concentrations in dams fed the control diet (12.3 6 7.7 nM) and in dams fed the SFA+B 12 diet (19.0 6 3.9 nM) (23) . Differentiation of 3T3-L1 cells was initiated by treatment for 3 d with 1 mM dexamethasone, 500 mM 3-isobutyl-1-methyl-xanthine, 1 mM rosiglitazone, and 1.5 mg/ml insulin (3T3-L1 Differentiation Kit-DIF001; MilliporeSigma), followed by treatment for 3 d with 1.0 mg/ml insulin. Differentiated adipocytes were maintained for an additional 3 d without insulin.
Following differentiation, mitochondrial respiration rates were determined with the Seahorse XFe96 Extracellular Flux Analyzer and Seahorse XF Mito Stress Test and Wave 2.3.0 software (Agilent Technologies) per the manufacturer's protocol. At baseline and after injection of each compound, oxygen consumption rates (OCRs) were measured 3 times, with each time point including a 3-min measurement cycle, followed by a 3-min mixing cycle. Data were normalized to protein concentration in each well, as determined with the Bradford Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA) and the Quick Start Bradford 1-Time Dye reagent (Bio-Rad Laboratories).
Basal respiration was calculated from the OCR curves using the following formula: basal respiration = last rate measurement before oligomycin injectionminimum rate injection after rotenone/antimycin A injection.
Maximal respiration was calculated using the following formula: maximal respiration = maximum rate measurement after carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) injection 2 minimum rate injection after rotenone/antimycin A injection.
Spare respiratory capacity was calculated using the following formula: spare respiratory capacity = maximal respiration ratebasal respiration rate.
Statistical analyses
Data are presented as means 6 SD. Statistical significance is set at P # 0.05. Interactions between maternal diet and offspring diet were determined by 2-way ANOVA. If a significant interaction was found, effects of maternal diet were determined separately in offspring fed the control diet and offspring fed the Western diet by 1-way ANOVA, followed by the least-significant difference test for multiple comparisons. Effects of folic acid and 5-MTHF on OCRs were assessed using repeated measures 2-way ANOVA. Effect of treatment on OCR parameters (basal respiration, maximal respiration, spare respiratory capacity) was assessed separately in folic acid and 5-MTHF-treated cells by 1-way ANOVA, followed by the least-significant difference test for multiple comparisons. Statistical analyses were performed with SPSS software (IBM, Armonk, NY, USA).
RESULTS
Glucose tolerance is dependent on offspring diet
The effects of maternal diet on offspring fasting blood glucose and plasma insulin levels were dependent on offspring diet; significant interactions between maternal diet and offspring diet were observed ( Fig. 1A, B) . In control diet-fed offspring, fasting blood glucose level was higher in SFA2B 12 offspring compared with control offspring. No effect of maternal diet was observed on fasting plasma insulin concentrations. Both the SFA2B 12 and SFA+B 12 offspring had greater area under the curve for the glucose excursion curves during the intraperitoneal glucose tolerance test suggesting greater glucose intolerance compared with control offspring (Fig. 1C, E) . Interestingly, we observed the opposite effect of maternal diet on glycemia and glucose tolerance in the offspring fed the Western diet. SFA2B 12 offspring had lower fasting blood glucose levels and lower fasting plasma insulin concentrations compared with control offspring (Fig. 1A,  B ). No significant differences in glucose tolerance were observed; however, SFA2B 12 and SFA+B 12 offspring had lower (but not significant) area under the glucose excursion curves, suggesting they had better glucose tolerance than the control offspring ( Fig. 1D, E) . Overall, these findings suggest the effects of maternal folic acid/ B 12 intake on offspring glycemia and glucose tolerance is dependent on offspring diet.
b cell mass and islet gene expression
We assessed b cell mass and islet gene expression as a first step toward a mechanistic understanding of the effects of maternal folic acid/B 12 intake on offspring glucose tolerance and fasting glycemia levels. We targeted expression of the following genes that encode transcription factors that have important roles in b cell proliferation and function: Mafa (32); Hnf1a, which encodes HNFa (33); and Nr1h3, which encodes liver x receptor a (34) . Similar to what we observed for glucose homeostasis, the effect of maternal diet on offspring pancreas b cell mass and islet gene expression was dependent on offspring diet. In control diet-fed offspring, SFA2B 12 and SFA+B 12 offspring had smaller pancreata ( Fig. 2A) , but only SFA2B 12 offspring had reduced b cell mass compared with control offspring (Fig. 2C) ; no effects on a cell mass were observed (Fig. 2B ). This was accompanied by greater Hnf1a mRNA and Nr1h3 mRNA expression in islets from SFA2B 12 offspring compared with control offspring (Fig. 2E, F) . In contrast, we found no effect of maternal diet on pancreas size or b and a cell mass in offspring fed the Western diet ( Fig. 2A-C) . However, lower islet Mafa mRNA expression in SFA+B 12 offspring compared with the control offspring ( Fig. 2D ) and lower islet Nr1h3 mRNA expression in SFA2B 12 offspring compared with the control and SFA+B 12 offspring were observed (Fig. 2F ). These findings suggest maternal folic acid supplementation with B 12 deficiency has a negative effect on b cell mass in female offspring fed a control diet but not in offspring fed the Western diet.
Body weight and adiposity
We determined whether effects on body composition and body fat distribution accompanied the effects of maternal diet on glucose tolerance. There was no effect of maternal diet on offspring body weight at weaning (Fig. 3A) ; however, an effect of maternal diet on offspring body weight, body composition, and body fat distribution was observed at 35 wk and was dependent on the postweaning diet. In offspring fed the postweaning control diet, we observed no effect of maternal diet on offspring total body weight ( Fig. 3B ). However, SFA+B 12 offspring had greater fat mass and lower lean mass than control offspring and SFA2B 12 offspring had (Fig. 3C, D) . This was accompanied by larger gonadal fat pads in SFA+B 12 offspring and SFA2B 12 offspring compared with control offspring (Fig. 3E ); no differences in retroperitoneal or inguinal fat pads were observed (Fig. 3F, G) .
Again, we observed a different effect of maternal diet on offspring adiposity in those fed the Western diet compared with those fed the control diet. The SFA2B 12 offspring gained less body weight during the postweaning period than control offspring and SFA+B 12 offspring did (Fig. 3B) . No effects of maternal diet on body composition or body fat distribution were observed ( Fig. 3C-F) , except that SFA2B 12 offspring had larger inguinal fat pads than SFA+B 12 offspring had (Fig. 3G ).
Liver methyl metabolism
As a step toward identifying how maternal folic acid/B 12 intake affects offspring glucose tolerance, b cells, and adiposity, we assessed methyl metabolism in the liver (Fig.  4A) . Maternal folic acid and B 12 intake had no effect on offspring serum B 12 or total folate concentrations ( Fig. 4B,  C) . However, maternal diet did affect other aspects of methyl metabolism. In offspring fed the control diet, liver AdoHcy concentrations were higher in SFA+B 12 offspring compared with control offspring and SFA2B 12 offspring (Fig. 4E ); no differences in AdoMet or the ratio of AdoMet/ AdoHcy were observed (Fig. 4D, F) . We further investigated expression of genes required for methyl metabolism and found less expression of liver Mtr mRNA in SFA+B 12 offspring and SFA2B 12 offspring compared with the control offspring (Fig. 4G) . Mtr encodes methionine synthase, which catalyzes the B 12 -dependent remethylation of homocysteine to methionine (Fig. 4A) (35) . In offspring fed the Western diet, we found lower liver AdoMet concentrations in SFA2B 12 offspring compared with control offspring (Fig. 4D) , and that was accompanied by higher liver Mthfr mRNA levels (Fig. 4H) . Mthfr encodes methylenetetrahydrofolate reductase, which is required for the formation of 5-MTHF; 5-MTHF is the folate form used by the B 12 -dependent methionine synthase remethylation of homocysteine to methionine (Fig.  4A ). Overall, these findings suggest that maternal folic acid and B 12 intake have lasting effects on liver methyl metabolism in adult female offspring, and that may contribute to the phenotypes observed in the mice.
Maternal folate/B 12 status and offspring IGF-1
We determined whether IGF-1 had a role in the female offspring phenotype because the growth hormone/IGF-1 axis is involved in adipogenesis (36) and a prior study by Roman-Garcia et al. (37) reported that maternal B 12 deficiency during pregnancy affected growth and bone formation in offspring through effects on the growth hormone/IGF-1 axis. In offspring fed the control diet, SFA2B 12 offspring had lower fasting serum IGF-1 concentrations compared with control offspring and SFA+B 12 offspring (Fig. 5A ); no effect of maternal diet on liver Igf1 and Igfbp2 mRNA expression ( Fig. 5B, C) or fasting serum leptin (Fig. 5D ) was observed. These findings suggest a potential role for IGF-1 in the phenotype observed in the SFA2B 12 offspring fed the control diet.
In offspring fed the Western diet, we found no effect of maternal diet on fasting serum IGF-1 and leptin concentrations and liver Igfbp2 mRNA; SFA+B 12 offspring had higher liver Igf1 mRNA levels than control offspring had (Fig. 5B) . 
Folates have direct effects on adiposity and adipocyte energy metabolism
To determine whether folate/B 12 status directly altered adipose tissue distribution, we assessed body weight and adiposity of the dams after 20-22 wk being fed the various diets at the time offspring were weaned. Dams fed the SFA2B 12 diet had greater (P , 0.05) total body weight and larger (P , 0.05) inguinal fat pads than dams fed the control diet had (Fig. 6A, B ); no effect of diet on gonadal fat pads and retroperitoneal fat pads was observed (Fig. 6C,  D) . These findings suggest an effect of folic acid supplementation with B 12 deficiency on adipose tissue accumulation and distribution in the dams.
Accordingly, we investigated the direct effects of folic acid or 5-MTHF, the predominant circulating folate form, on adipocyte energy metabolism as a potential reason for the greater weight gain and adiposity in the dams fed the SFA2B 12 diet. To do so, we treated mouse 3T3-L1 adipocytes with folic acid or 5-MTHF at the following concentrations: 0.16 mM (serum total folate concentrations in control mice), 0.8 mM (5 times the control), and 1.6 mM (10 times the control) and assessed mitochondrial respiration by analyzing extracellular OCRs. We observed differential effects of folic acid and 5-MTHF on OCR. Cells treated with 1.6 mM folic acid had lower OCRs than did cells treated with 0.16 mM folic acid (Fig. 6E) , whereas cells treated with 1.6 mM 5-MTHF had higher (P , 0.05) OCRs than cells treated with 0.16 mM 5-MTHF had (Fig. 6F) . No effects of folic acid or 5-MTHF treatments were observed on basal mitochondrial respiration (Fig. 6G) ; however, greater (P , 0.05) maximal respiration and spare respiratory capacity were observed in adipocytes treated with 1.6 mM 5-MTHF than in those treated with 0.16 mM 5-MTHF (Fig. 3H, I) .
DISCUSSION
In the present study, we investigated the effects of maternal folic acid/B 12 intake during pregnancy and lactation on adiposity and glucose homeostasis in adult female offspring mice to explore mechanisms underlying epidemiologic reports of associations between maternal high folate status and/or B 12 deficiency during pregnancy and greater adiposity and insulin resistance in children (11) (12) (13) . This study is a follow-up to our recent study that reported a positive effect of maternal folic acid supplementation, but no effect of maternal vitamin B 12 status, on adiposity and vascular health in adult, male, offspring were fed the postweaning control diet (23) . In the current study, we report 3 major findings. First, the effect of maternal folic acid/B 12 intake on adult female offspring health was dependent on offspring postweaning diet. In offspring fed a control diet, we observed adverse effects of maternal folic acid supplementation with B 12 deficiency. The offspring mice had a phenotype similar to what is reported in the epidemiologic studies (11) (12) (13) , with greater adiposity, glucose intolerance, and hyperglycemia. However, that contrasts with what we observed in offspring fed the Western diet from dams supplemented with folic acid and B 12 deficiency. Those offspring gained less weight and were less glucose intolerant. Second, the differential phenotypes observed in the offspring were accompanied by effects of maternal diet on pancreas size, b cell mass, islet gene expression, and hepatic methyl metabolism, suggesting roles for the pancreas and liver in the maternaldiet-induced differences in offspring glucose homeostasis. Third, our observations in the offspring may be due to dietinduced effects on adiposity in the dams. The dams that were supplemented with folic acid but were B 12 deficient (SFA2B 12 dams) had elevated body weights and greater adiposity. Further, we provide evidence that folic acid has direct effects on adipocyte mitochondrial function. As such, the greater adiposity in the SFA2B 12 dams may elicit a cascade of signals to the developing offspring and contribute to the offspring phenotype.
The greatest metabolic dysfunction was observed in control diet-fed female offspring from dams fed the folic acid supplemented diet with B 12 deficiency. Interestingly, reduced b cell mass accompanied the fasting hyperglycemia and impaired glucose tolerance in those offspring. There are several reports in the literature on effects of maternal diet or other environmental exposures during gestation eliciting effects on b cell mass and disturbances in glucose homeostasis in adult animals (38) (39) (40) (41) ; however, none, to our knowledge, have reported that offspring from dams that were deficient in B 12 and/or supplemented with folic acid had such effects. Interestingly, the reduced b cell mass in the SFA2B 12 offspring was accompanied by greater islet Hnf1a and Nr1h3 mRNA expression. Islet expression and activity of Hnf1a is tightly regulated. Both deficiency or elevations of Hnf1a expression is associated with disturbances in b cell proliferation and reduced b cell mass, leading to disturbances in glucose homeostasis (33) . Our finding that Hnf1a expression was elevated in the offspring with lower b cell mass suggests the maternal SFA2B 12 diet elicited some b cell dysfunction in the offspring. Similar findings of reduced b cell mass accompanied by greater Hfn1a expression have also been reported in young (aged 7 and 21 d), male Wistar rat offspring from dams fed a low-protein diet during pregnancy and lactation (41) .
No other groups, to our knowledge, have reported on the combined effects of folic acid supplementation with B 12 deficiency in animal models. Most of the published animal studies have focused on maternal folate and/or B 12 restriction or on supplementing maternal diet with multiple methyl nutrients in addition to folic acid and B 12 (19) (20) (21) (22) . The former does not recapitulate the high-folate status in the general North American population (6) (7) (8) (9) ; the latter poses challenges when attempting to delineate the effects of each nutrient on offspring phenotype and its relevance to humans. We aimed to better parallel the situation in humans by supplementing our maternal diets with 5 times more folic acid, compared with the control diet; however, 5 mg/kg folic acid in the supplemented diets is 10 times the U.S. National Research Council requirement for mice (42). In comparison, recommendations for women who are planning a pregnancy or who are pregnant is that they take a supplement containing 0.4 mg/d folic acid; however, prenatal supplements typically contain 0.8-1.0 mg folic acid (43) . Recommendations are much higher for women at risk for an NTD-affected pregnancy, including women with pregestational obesity (body-mass index $30 kg/m 2 ), with 5 mg/d folic acid recommended; that is 5 times greater than the levels observed in standard prenatal supplements in North America and 12.5 times greater than the recommendations for women at low risk for an NTD-affected pregnancy (43) .
The differences in diets, species, and strains of animals reported in the literature make effective comparisons difficult. For example, 1 group (20) reported on effects of maternal folic acid deficiency or B 12 deficiency or a combination of both deficiencies in a Wistar rat model and found that male offspring from dams fed the folic acid-or B 12 -deficient diets had greater body weight and adiposity, but glucose tolerance and female offspring were not assessed. Several other groups (16) (17) (18) have reported on effects of maternal folic acid supplementation (with adequate B 12 ) on offspring metabolic health; however, the findings were inconsistent and also vary by animal type and level of folic acid supplementation. Further, most published studies only report on effects in male offspring, with the exception of 2 studies (16, 18 ) that compared male and female offspring. One of those studies (16) reported elevated fasting plasma glucose concentrations in adult female offspring Wistar rats from dams fed a diet supplemented with 5 times more folic acid than controls; no effects were observed in the male offspring. Similarly, another study in Sprague-Dawley rats (18) reported that female offspring, but not male offspring, from dams fed a diet supplemented with 20 times more folic acid than controls, had greater weight gain and glucose intolerance. Nonetheless, these findings are similar to what we report here in the control diet-fed, female offspring and in our previous report (23) of no adverse phenotype in adult, male offspring from folic acid-supplemented dams.
Interestingly, we observed that offspring from dams supplemented with folic acid and deficient in B 12 were less susceptible to the effects of a Western diet; those offspring gained less weight, were less glucose intolerant, and did not have fasting hyperglycemia or hyperinsulinemia, which are typical characteristics of mice fed a Western diet. This contrasts with a report by Keating et al. (18) who reported greater weight gain and adiposity in female rat offspring given fructose in drinking water (10%) and who were from dams supplemented with 20 times folic acid. Similarly, another study (17) reported greater adiposity, glucose intolerance, and hyperinsulinemia in high-fat diet-fed adult, male, offspring mice from dams supplemented with 20 times folic acid. Although direct comparison is not possible because of differences in study design, those findings suggest that the higher level of folic acid supplementation, 20 times compared with 5 times, is not beneficial to offspring challenged with an obesogenic diet. Of note, the epidemiologic studies did not include consideration of the child's diet or other lifestyle factors when assessing relationships between maternal B vitamin status during pregnancy and adiposity and insulin resistance in the children (11) (12) (13) . Overall, these findings advocate for the importance of considering the child's diet and other lifestyle factors that influence adiposity and insulin resistance, such as physical activity, in models assessing relationships between maternal nutrient status in pregnancy and the metabolic health of the child.
One of the other mechanisms we explored in this study was whether the maternal diets affect adiposity in the dams, which lead to subsequent effects in the offspring. Indeed, we observed that dams of offspring with the greatest metabolic dysfunction also gained the most weight and had greater adiposity. Little is known about the effects of folic acid on adipocyte and lipid metabolism. A recent study has reported greater triglyceride accumulation in 3T3-L1 adipocytes treated with excess folic acid (44) . Further, a study in adult male mice supplemented with 20 mg/kg folic acid reported altered expression of genes required for lipid metabolism in the liver (45) . As such, we investigated the direct effects of folic acid on mitochondrial function and observed that, at higher concentrations, folic acid reduced overall mitochondrial respiration, whereas 5-MTHF, the main circulating form of folate, increased mitochondrial respiration. Unmetabolized folic acid is present in the circulation at high folic acid intakes (46, 47) ; therefore, our findings provide evidence to support the concerns regarding effects of unmetabolized folic acid (3, 48) . However, the folic acid concentrations used in that part of our study were based on circulating concentrations of total folates and were higher than that for unmetabolized folic acid.
In summary, we report that maternal folic acid supplementation with B 12 deficiency during pregnancy/ lactation determines the metabolic health of adult female offspring but is dependent on offspring diet and involves effects of maternal diet on maternal adiposity and on offspring b cells. Further investigations are required to further elucidate the mechanisms underlying effects of folic acid and B 12 on b cell development and function. Additional studies are also required to determine effects of maternal folic acid supplementation with B 12 deficiency on other phenotypes in the offspring. For example, a recent study (49) reported altered brain development and cognition in young offspring from dams fed a folic acid supplemented diet (20 mg/kg diet) during pregnancy and lactation. Further, the contribution of paternal folic acid/ B 12 intakes on offspring health also warrants investigation; recent evidence suggests paternal B vitamins and other methyl donors influence adult offspring phenotype (50) .
